A Mediterranean diet with moderate calorie cuts, combined with regular exercise, reduced the risk of developing type 2 diabetes by 32% in older adults who were already at high metabolic risk, according to a study published in Annals of Internal Medicine in May 2026. The finding is striking not just for the size of the effect but for what it did not require: participants did not need to lose large amounts of weight to see the benefit.
The results come from PREDIMED-Plus, a multicenter randomized controlled trial conducted across 23 research sites in Spain. Led by researchers including Jordi Salas-Salvadó of Universitat Rovira i Virgili, the trial enrolled 6,874 adults between the ages of 55 and 75 who had overweight or obesity along with metabolic syndrome, a cluster of conditions that includes elevated blood sugar, high blood pressure, excess abdominal fat, and abnormal cholesterol or triglyceride levels. Metabolic syndrome is one of the strongest predictors of progression to type 2 diabetes.
What the trial tested
Participants were randomly assigned to one of two groups. The intervention arm followed an energy-reduced Mediterranean diet, targeting a daily reduction of roughly 300 calories, paired with a structured physical activity program and ongoing behavioral counseling sessions. The control arm received standard advice to follow a Mediterranean diet with no calorie targets, no exercise plan, and no behavioral support.
Both groups ate diets rich in olive oil, vegetables, legumes, fish, nuts, and whole grains. The difference was the added structure: calorie awareness, movement goals, and regular check-ins with dietitians and exercise specialists. Over a median follow-up of approximately 4.1 years, the intervention group developed type 2 diabetes at a significantly lower rate than the control group, with a hazard ratio of 0.68. In practical terms, that translates to roughly one-third fewer new diabetes cases in the group that received the full lifestyle program.
The weight difference between the two groups was modest, averaging around 1 kilogram at the end of follow-up. That gap is far smaller than what most diabetes prevention guidelines have historically demanded. The landmark U.S. Diabetes Prevention Program (DPP), published in 2002, showed a 58% reduction in diabetes risk, but it required participants to lose at least 7% of their body weight, a target many people find difficult to reach and even harder to maintain. PREDIMED-Plus suggests that improving diet quality and adding consistent exercise can deliver meaningful protection even when the scale barely moves.
Why the design matters
This was a secondary analysis, not the trial’s original primary endpoint. PREDIMED-Plus was designed primarily to study cardiovascular outcomes, and the diabetes prevention data emerged from examining a pre-specified secondary outcome within that larger dataset. That distinction carries real methodological weight. Secondary analyses can identify genuine effects, but they can also surface findings that might not hold up in a trial built from the ground up to test that specific question.
That said, the trial’s randomized controlled design gives it a significant advantage over observational studies, which can show correlations between eating patterns and disease risk but cannot establish causation with the same confidence. Randomization reduces the chance that hidden differences between groups, rather than the intervention itself, explain the outcome. The large sample size and multi-year follow-up add further credibility. A press release from the research team described the risk reduction as “nearly one-third,” consistent with the published hazard ratio.
Open questions and limits
Several uncertainties remain. The follow-up period, while long enough to detect a statistically significant difference, does not reveal whether the protective effect lasts a decade or more. Previous lifestyle intervention trials, including the DPP, have shown that early metabolic gains can erode once structured support ends and participants drift back toward old habits.
Adherence data at the individual level have not been reported in granular detail. Summary-level figures show that the intervention group reduced calorie intake and increased physical activity, but it is unclear how closely the average participant stuck to the plan over time, or whether the benefit was concentrated among the most compliant individuals. That gap limits conclusions about how much diet change and how much exercise are truly needed to move the needle.
Geography and culture also matter. The trial was conducted entirely in Spain, where Mediterranean dietary patterns are culturally embedded and ingredients like extra-virgin olive oil, fresh fish, and seasonal produce are widely available and affordable. Whether the same intervention would produce equivalent results in populations with different food environments, dietary traditions, or levels of healthcare access is an open question. Adapting the protocol for North American, Asian, or sub-Saharan African populations would require careful cultural translation, not just menu swaps.
It is also worth noting the scale of the problem these findings address. More than 500 million adults worldwide now live with type 2 diabetes, according to the International Diabetes Federation, and the number is projected to keep rising as populations age and obesity rates climb. Even a 32% risk reduction, applied broadly, could prevent millions of new cases, but only if the intervention can be delivered outside the controlled environment of a clinical trial.
What this means for people at risk
For anyone with metabolic syndrome or prediabetes, the practical signal from PREDIMED-Plus is encouraging and specific. A Mediterranean eating pattern with a moderate calorie reduction of roughly 300 calories per day, combined with regular physical activity and some form of structured accountability, produced meaningful protection in a rigorous trial. The benefit did not depend on aggressive dieting or heavy exercise. It depended on consistency: better food choices, steady movement, and regular support.
That combination is closer to what most people can realistically sustain than the steep weight-loss targets that have dominated diabetes prevention advice for two decades. It does not replace the evidence behind the DPP or the value of weight loss for those who can achieve it. But it does expand the menu of evidence-backed options, particularly for older adults who may find large-scale weight loss physiologically harder and less sustainable.
Anyone considering acting on these findings should start with a conversation with a physician or registered dietitian. The trial’s behavioral support component, which included group counseling and regular check-ins, appears to have been a key ingredient in helping participants maintain changes over years rather than weeks. Replicating that support, whether through a healthcare provider, a community program, or even a structured digital platform, may be just as important as the dietary and exercise changes themselves.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
